MSc Medical Biotechnology
The master's programme in Medical Biotechnology provides a solid foundation for the development of sustainable biotechnological solutions and their use in health care. Students acquire knowledge about state-of-the-art techniques, experience in operating technological platforms and analyzing big data in the context of human health. Graduates have the competence necessary to research and develop diagnostics, disease prevention tools and therapies.
Medical Biotechnology at KTH
This two-year master’s programme comprises advanced courses that focus on tools used to analyse a variety of biological samples for life science research, as well as for health care applications within diagnostics and drug development. The student will be provided with in-depth knowledge about scientific methodologies used for comprehensive analyses of biological systems, and their applications for advanced health care or medical surveillance. The programme offers extensive biotechnology training to tackle global needs in the area of life sciences thus enabling students to prepare for careers both in Sweden and internationally.
The programme offers two tracks: medical applications of biotechnology and omics, each corresponding to half-time studies. The tracks are designed to provide specialization within the specific biotechnology fields. The student shall complete all courses within at least one chosen track. Students are able to tailor their education by combining their chosen track with a second track either from the same programme, or any of the three tracks at the master’s programme in Industrial and Environmental Biotechnology. It is also possible to cherry pick courses from any the mentioned tracks to create one’s own unique professional profile.
Courses comprise both theoretical knowledge and practical application of theory from experimental design to bioinformatic and statistical analysis of raw data and interpretation of results. The curriculum provides a cross-platform approach that enables students to acquire a unique and individualised expertise that appeal to a wide span of employers. Students train problem-solving skills, project management as well as professional communication. During the last term of the programme students work with a master degree project in a research setting at KTH, in industry or in a university or research institute anywhere in the world and acquire specialisation within a relevant topic.
The programme curriculum is designed, taught and continuously updated by a team of internationally recognised researchers within the different subject areas, in collaboration with representatives from the private sector. The programme is given by the School of Engineering Sciences in Chemistry, Biotechnology and Health in Stockholm with access to facilities, infrastructure and instrument park available at at Solna Campus (Science for Life Laboratory) and KTH Campus in Stockholm (AlbaNova University Center).
Find out what students from the programme think about their time at KTH.
The combination of technology, biology and bioinformatics taught in the master’s programme in Medical Biotechnology provides an attractive profile for a professional career in the biotechnological and pharmaceutical industry, or for further academic studies. These areas are expanding worldwide, which gives a graduate in Medical Biotechnology opportunities for a career in companies involved in the manufacturing of drugs, medical analyses and diagnostics, or further work in academic preclinical research, research policy, journalism, patent agencies, or as consultant. Half of the graduates pursue with higher education to accomplish a doctoral degree.
Graduates from KTH have the knowledge and the necessary tools to improve the society in a sustainable way, as sustainable development is an integral part of all programmes. The Medical Biotechnology field creates and maintains sustainable solutions to societal challenges regarding human health. Sustainability is a key aspect that features in all areas of Biotechnology, from genomic, transcriptomic and proteomic characterisation of whole organisms, to the development of diagnostics and therapies. The three key sustainable development goals that are best aligned with the master's programme in Medical Biotechnology are:
The master’s programme in Medical Biotechnology focuses on cutting-edge technologies used to explore biomolecules in humans at a holistic-level, as well as providing understanding about how biological processes function and are altered in disease. The acquired knowledge is applied to the design of innovative diagnostic tools, drugs and therapies capable of curing diseases and improving human health. Besides knowledge about how health and life quality can be improved, the programme also focuses on how technology can be used to characterize the interplay between humans and populations of other microorganisms, and how such knowledge can be used to benefit the development of a sustainable society and preserve life.
Faculty and research
The School of Engineering Sciences in Chemistry, Biotechnology and Health conducts research in both fundamental and applied sciences with an emphasis on the medical aspects of human biology and the development of technical applications for medical care. The research activities conducted are multidisciplinary in nature, bringing together technology, medicine and bioinformatics. Active researchers are internationally well recognised, and conduct collaborative projects with leading international scientists as well as companies within the biotechnology private sector.
The School of Engineering Sciences in Chemistry, Biotechnology and Health at KTH conducts research in both fundamental and applied sciences with an emphasis on the medical aspects of human biology and the development of technical applications for medical care. The research activities conducted are multidisciplinary in nature, bringing together technology, medicine and bioinformatics. Active researchers are internationally well recognised, and conduct collaborative projects with leading international scientists as well as companies within the biotechnology private sector.
- Department of Gene Technology (Division of Genomics, Environmental Genomics, Evolutionary Biology and Forensics, Experimental Genomics, Expression Bioinformatics, and Statistical Biotechnology.)
- Department of Protein Science (Division of Affinity Proteomics, Cellular and Clinical Proteomics, Drug Discovery and Development, Nanobiotechnology, Protein Engineering, Protein Technology, and Systems Biology.)
- Department of Theoretical Chemistry and Biology